GlobeNewswire 2021-01-20 Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
GlobeNewswire 2021-01-05 CORRECTION -- Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2021-01-05 Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2021-01-05 Myovant Sciences Announces U.S. Availability of ORGOVYX™ for the Treatment of Advanced Prostate Canc...
GlobeNewswire 2021-01-04 SUMITOVANT BIOPHARMA ANNOUNCES THE APPOINTMENT OF INDUSTRY VETERAN, DAVID MAREK, AS CHIEF EXECUTIVE...
GlobeNewswire 2021-01-04 Myovant Sciences Appoints Industry Veteran David Marek as Chief Executive Officer
GlobeNewswire 2020-12-28 UPDATE - Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop a...
TeleTrader 2020-12-28 Myovant and Pfizer sign partnership
GlobeNewswire 2020-12-28 Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commer...
GlobeNewswire 2020-12-28 Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncolog...
GlobeNewswire 2020-12-23 Sumitovant Biopharma Announces Urovant Sciences Receives U.S. FDA Approval of GEMTESA® (vibegron) 75...
GlobeNewswire 2020-12-18 Sumitovant Biopharma Announces Myovant Sciences receives FDA Approval of ORGOVYXTM (relugolix), the ...
GlobeNewswire 2020-12-18 Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropi...
GlobeNewswire 2020-12-16 Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
GlobeNewswire 2020-11-23 Myovant Sciences to Present at Upcoming December Investor Conferences
GlobeNewswire 2020-11-17 Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
GlobeNewswire 2020-11-12 Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 20...
GlobeNewswire 2020-11-02 Myovant Sciences to Host Second Fiscal Quarter 2020 Earnings Conference Call at 8:30 a.m. Eastern Ti...
GlobeNewswire 2020-10-21 Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometri...
GlobeNewswire 2020-10-14 Myovant Sciences Appoints Ryan Crowe as Vice President, Investor Relations
GlobeNewswire 2020-09-29 Myovant Sciences Announces Results of Additional Secondary Endpoint of Castration Resistance-Free Su...
GlobeNewswire 2020-09-23 Myovant Sciences Launches “Forward for Health Equity” Grant Program to Improve Healthcare Access in ...
GlobeNewswire 2020-09-14 Myovant Sciences Presents Additional Data on Bone Mineral Density in Women with Uterine Fibroids fro...
GlobeNewswire 2020-09-10 Sermonix CEO David Portman to Participate in Women’s Health Innovation Virtual Summit
GlobeNewswire 2020-08-17 Myovant Sciences Announces FDA Acceptance of New Drug Application for Once-Daily Relugolix Combinati...